Spots Global Cancer Trial Database for nilotinib 200mg
Every month we try and update this database with for nilotinib 200mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Nilotinib Plus Dabrafenib/Trametinib in Metastatic Melanoma | NCT04903119 | Metastatic Mela... BRAF Gene Mutat... | Nilotinib 100mg Nilotinib 200mg Nilotinib 300mg Nilotinib 400mg Dabrafenib Trametinib | 18 Years - | University of Kentucky | |
Nilotinib Plus Dabrafenib/Trametinib in Metastatic Melanoma | NCT04903119 | Metastatic Mela... BRAF Gene Mutat... | Nilotinib 100mg Nilotinib 200mg Nilotinib 300mg Nilotinib 400mg Dabrafenib Trametinib | 18 Years - | University of Kentucky |